Genes associated with similar diseases are often functionally related. This principle is largely supported by many biological data sources, such as disease phenotype similarities, protein complexes, protein-protein interactions, pathways and gene expression profiles. Integrating multiple types of biological data is an effective method to identify disease genes for many genetic diseases. To capture the gene-disease associations based on biological networks, a kernel-based Markov random field (MRF) method is proposed by combining graph kernels and the MRF method. In the proposed method, three kinds of kernels are employed to describe the overall relationships of vertices in five biological networks, respectively, and a novel weighted MRF method is developed to integrate those data. In addition, an improved Gibbs sampling procedure and a novel parameter estimation method are proposed to generate predictions from the kernel-based MRF method. Numerical experiments are carried out by integrating known gene-disease associations, protein complexes, protein-protein interactions, pathways and gene expression profiles. The proposed kernel-based MRF method is evaluated by the leave-one-out cross validation paradigm, achieving an AUC score of 0.771 when integrating all those biological data in our experiments, which indicates that our proposed method is very promising compared with many existing methods. disease gene identification, data integration, Markov random field, graph kernel, Bayesian analysis
The availability of large-scale biological networks provides an opportunity to comprehensively identify disease genes of many genetic diseases, by synergizing evidences from multiple types of data sources. Various algorithms [1] [2] [3] [4] [5] [6] have been developed to identify human disease genes based on the strategy of multiple data integration.
However, challenges still exist due to the following reasons. Firstly, there are many levels of controls along paths from genotypes to phenotypes [7] , resulting in the indirect relationship between genotypes and phenotypes [8] . Secondly, different biological data are heterogeneous and describe relationships of molecular entities in various levels. It is not a trivial task to design a good algorithm that combines those data appropriately. Thirdly, many data integration methods simply assume that disease genes of similar diseases exhibit dense clusters in the integrated networks, but ignore the fact that those networks are built independently from the description of gene-disease association relationships.
The Markov random field (MRF) model proposed by Deng et al. [9, 10] for predicting yeast protein functions provides a good framework to integrate multiple biological networks. The issue of protein function prediction is formulated as a Bayesian labeling problem, where the function labels follow a Gibbs distribution. A binary logistic regression is employed to estimate parameters from known observations, and a Gibbs sampling approach is developed to generate final predictions. Advantages of the MRF method include its simplicity, its ability to explore contributions of direct neighbors, and its flexibility to integrate multiple types of datasets.
Although the issue of yeast protein function prediction is similar to the issue of human disease gene identification, the method of Deng et al. [9, 10] cannot be directly employed to identify human disease genes. Parameters of the MRF model cannot be estimated precisely due to the limited observations of human disease genes, which make predictions of their method unreliable. Kourmpetis et al. [11] then proposed a Bayesian MRF method to estimate parameters iteratively together with the update of posterior probabilities of function labels during the Gibbs sampling process. However, their method uses another predefined scaling parameter , a Z matrix and a multivariate normal distribution to perform the estimation, which makes the method a little complex. Ma et al. [5] proposed a combining gene expression and protein interaction data (CGI) method to identify genes responsible for similar phenotypes or traits, motivated from the MRF model of Deng et al. [9, 10] . Similarity metric defined by the diffusion kernel is also compared with those by direct neighbors and shortest paths, where predictions from the diffusion kernel are greatly improved. However, the CGI method mainly uses gene expression profiles to group genes with similar characters. Protein interaction data are only employed to calibrate predictions. It is not clear how to integrate other types of biological data by using their method. Lee et al. [12] developed a kernel logistic regression (KLR) method for predicting yeast protein functions by combining advantages of both the MRF model and diffusion kernels. Although its predictive accuracy is higher than that of the original MRF method of Deng et al. [9, 10] , the parameter estimation problem still exists if the KLR method is employed to identify human disease genes. Other forms of MRF methods can be found in [13] [14] [15] .
Graph kernels, on the other hand, have shown their powers for interpreting complex relationships of vertices in biological networks [16] [17] [18] . A kernel-based algorithm often yields better performance than those using direct neighbors or shortest paths under the same condition. In papers [19, 20] , we have developed a modified MRF model for human disease gene prioritization. In this study, we further propose a kernel-based MRF algorithm for identifying disease genes from multiple types of data by combining the MRF model and graph kernels. The kernel-based MRF algorithm is different from the methods proposed in [19, 20] in the following four aspects. Firstly, a novel weighted MRF method is developed for incorporating different graph kernels. Secondly, a new parameter estimation method is designed for the kernel-based MRF method based on global characters of biological networks. Thirdly, an improved Gibbs sampling strategy is proposed which takes the weight value of neighbors into consideration, rather than simply counting the number of neighbors attributed specific values. Finally, the kernel-based MRF method is extended to integrate multiple types of data sources, such as protein-protein interaction (PPI) networks, pathway co-existing networks and gene co-expression networks. We show that the kernel-based MRF algorithm can significantly improve the accuracy of disease gene identification compared with existing methods.
Methods

Problem statement
Suppose a human genome consists of a set of N genes 
. To achieve this, a vector of ran-
is defined corresponding to x , where P(X i  x i ) represents the probability that X i  x i . The objective is to find the posterior prob-
Markov random field
Let G  (V, E) be a graph with N vertices and
be a vector of random variables defined on V. The vector X is said to be a MRF on G if and only if the following two conditions are satisfied:
where X are the set of all possible outcomes of X i ,
, and X N (i) is the collection of all X j for j  N (i), where N(i) is the set of all neighbors of vertex i in G. The neighborhood structure of graph G is denoted as N . The Markovianity indicates that the probability of X i is conditionally independent on all other X k except the value of its neighbors. A joint event
One of the key features that facilitate the practical usage of MRF is its equivalence with the Gibbs random filed, which is established by the Hammersley-Clifford theorem [21, 22] . According to the theorem, X is a MRF on V w.r.t.
N if and only if the probability distribution of P(X) follows a Gibbs distribution. The Gibbs distribution has a form of
where Z  e 
where V i (x) is the clique potential of C i (the set of ith order cliques in G), R n (x) represents those higher order terms. A special case of MRF is the Ising model that only considers up to the second order of cliques [24] , which is also the same as many existing MRF methods did in [10, 11, 20] . The practical valuation of the Hammersley-Clifford theorem is that it gives a simple way to specify the probability P(X) by using those clique potentials. Suppose X i is a binary random variable (i.e., taking values zero or one). Let 10 , and V 2 (0, 0)   00 . Let N 11 , N 10 and N 00 be the number of edges whose two endpoints have both the attribute values of 1, one attribute value of 1 and the other value of 0, and both the attribute values of 0, respectively. Then the energy function (3) of the MRF can be written as 11 11 00 00 10 10
where   (,  11 ,  10 ,  00 ) are parameters.
To generate predictions from a MRF model, the value of parameter  is necessary, which is generally unknown. The most natural approach to estimate  is through the maximum likelihood estimation (MLE) method. However, the MLE method is often intractable in this situation, since the normalizing partition function Z is also a function of parameters. Fortunately, the pseudo-likelihood approach and the Gibbs sampling process provide a solution for estimating parameters and generating predictions from a MRF model. Firstly, for estimating parameters, suppose parameters   (,  11 ,  10 ,  00 ) of (4) are given. Then fixing the value of X i , the energy function of (4) can be rewritten as
and
respectively, where U(X [i ] ) represents the energy contributed by all cliques that do not contain vertex i. Hence, according to the Bayes' theorem [25] and (2), (5) and (6), we have
The log-odds of the probability P(
where ( 1) 
, , , X X X  clearly forms a Markov chain.
Graph kernels
Kernels provide a general framework to represent data in the form of pairwise similarities. Generally, two mathematical conditions need to be satisfied that make a function k serving as a kernel: (i) it must be symmetric ( ( , ) 
where u, v represents the dot product in the Hilbert space between any two points u, v  H .
The definition of a kernel is a critical component of any kernel method, since it defines how an algorithm "sees" the data. The graph representation of a biological network is often used to describe local topological relationships, which is often not enough to capture the distant relationships among biomolecules. Alternately, a graph kernel based representation provides a solution for this by considering global topological structures [16, 18] .
One of the most commonly used graph kernel of G is the Laplacian exponential diffusion (LED) kernel [16] , where the kernel matrix is defined as
where L D A   is the Laplacian matrix of the graph G, A is the adjacency matrix, and D is a diagonal matrix with the ith diagonal element d(i) being the degree of the vertex i and all off-diagonal elements being 0. The parameter  controls the magnitude of the diffusion, which is often chosen as a very small number. In this study, we take   0.04 as [7] suggested.
A diffusion kernel defines the similarity of biomolecule pairs by considering all pairwise relationships within a network. However, diffusion kernels between different biological networks may not be comparable when a method needs to integrate multiple data sources. To overcome this problem, Chen et al. [7] propose a measure, called DKPC, to normalize pairwise similarities based on their relative strengths among all similarities within a network. The DKPC value between a vertex pair i and j is defined as
where ij K is a similarity value of vertex pair i and j in a kernel matrix. A smaller value of DKPC(i, j) indicates that two vertices i and j are more similar. However, in the K LED matrix, it uses larger values to represent relationships of vertices are more similar. To be consistent, we use the complementary value DKPCij  1 DKPC(i, j) to represent the normalized similarity between vertex pair i and j that is obtained from the DKPC method hereafter. Generally, the above two kernels are strongly related to the degree of individual vertices, where the kernel value between two high degree vertices is significantly different from that between two low degree vertices. To make the strength of individual vertices comparable, we propose a Markov exponential diffusion (MED) kernel in this study by replacing the Laplacian matrix L in (11) with a Markov matrix M, which consists of nonnegative real numbers with each row and column summing to 1. The MED kernel matrix is defined as follows:
where M  (N  I  D  A) N and N is the number of vertices in the network.
Kernel-based MRF method
Let K NN be a kernel matrix derived from a biological network, where all diagonal elements are set to be zero (since the purpose of disease gene identification is to obtain a set of novel candidate genes according to the knowledge of known disease genes, the similarity metrics between a gene and itself are neglected 
respectively, where K ij is the entry in the ith row and jth 
weighted form is then defined as
Secondly, an improved Gibbs sampling method is proposed that can iteratively estimate and update parameters  simultaneously with the change of posterior probabilities. Suppose a prior probability of p can be randomly generated according to the prior probability. Then the pseudo-likelihood parameter estimation method can be performed on the whole network, including those known vertices and those unknown vertices, by using (16) . Once those parameters are obtained in this iteration, the posterior probabilities of each vertex p i can then be updated according to (16) as well. Repeat this process for many times until both of them are stable. The step-by-step description of this Gibbs sampling procedure is given as follows. S1. Initialization:
Let t  0 . Initialize the prior probabilities for unknown 
, and go to S2, until t is larger than a predefined iteration step. The details of how this predefined iteration step is set are given in the Experimental design section. The improved Gibbs sampling procedure above is different from existing MRF methods [10, 13, 23] in two aspects. First, parameters of the improved method are estimated according to the configuration and the posterior probability of the whole network, while most existing MRF methods are based on subnetworks that consist of only known vertices. Ignoring the majority of unknown vertices makes the value of M i1 and
w ' and M i 0 w ' in this study) inaccurate, and then parameters cannot be estimated precisely. Predictions become unreliable if those inaccurate parameters are used to identify human disease genes. Second, many existing MRF methods estimate parameters only once. Parameters are then fixed during the entire Gibbs sampling process [10, 13, 23] . This is very dangerous if parameters are not estimated precisely. In our method, parameters are updated iteratively together with the change of all posterior probabilities. The Gibbs sampling process always takes the most updated parameters to estimate posterior probabilities for all unknown vertices, which is expected to generate more reliable predictions. Finally, the proposed MRF method is extended for incorporating multiple types of biological networks. Suppose there are L networks 1 ( , , )
, where vertices represent genes and edges represent specific biological relationship between vertices. Eq. (16) can be easily extended as (17), when estimating parameters and updating posterior probabilities during the iterations.
Experimental design
Data Sources
Known gene-disease associations are collected from the Morbid Map list of the Online Mendelian Inheritance in Man (OMIM) [26] . Goh et al. [27] classify all those diseases into 22 primary disease classes, including a 'multiple' class and an 'unclassified' class. The dataset consists of 1284 diseases and 1777 disease genes. In this study, we choose those disease classes that consist of at least 30 genes and exclude the 'multiple' class, the 'unclassified' class, the 'cancer' class and the 'neurological' class due to the lack of their class evidence and the class heterogeneity [27] . The final dataset consists of 815 genes in 12 disease classes.
Two sets of protein complexes are collected from the database of CORUM [28] and PCDq [29] , which contain 1677 and 1103 protein complexes that consist of at least two proteins, respectively. All those protein complexes are employed to assign the prior probabilities for unknown vertices.
Three PPI networks are derived from the database of HPRD (Release 9) [30] , BioGrid (Release 3.2.108) [31] Pathway datasets are obtained from the database of KEGG [40] , Reactome [41] , PharmGKB [42] and PIN [43] , which contain 280, 1469, 99 and 2679 pathways, respectively. A pathway co-existing network is constructed by taking individual proteins/genes as vertices. Edges are constructed between two vertices if they co-exist in any pathway.
A gene co-expression network is constructed by using the dataset of BioGPS (GSE1133) [44, 45] . It contains 79 human tissues in duplicates, which are measured by using the Affymetrix U133A array. Pairwise Pearson correlation coefficients (PCC) are calculated and a pair of genes are linked by an edge if the PCC value is larger than 0.5, similar to the method used in [7, 27] .
Overall, five biological networks are constructed and all protein (or gene) IDs are mapped onto the form of the gene symbol. In order to test the performance of multiple data integration of our method, we select those genes that appear at least in four networks. The final datasets consist of 7311 human genes, 815 out of which are known to be associated with 12 disease classes.
Estimating a prior probability
To perform a Gibbs sampling procedure, a set of prior probabilities for all vertices is needed. Generally, the values of those prior probabilities do not have significant effect on the final stabled state of a Markov chain if enough iterations are performed. However, a good prior does help to reduce the time of iterations to achieve the stable state.
For those known disease genes, the prior probability of obs 1 (  , ,  ) n nm p p p     can be assigned determinedly according to known gene-disease associations. The value of p j , n 1  j  n  m equals 1 or 0 depending on the analyzed disease class and those known gene-disease associations.
For those unknown disease genes, since genes that encode proteins in a same complex tend to associate with similar diseases, we estimate their prior probabilities according to the protein complex information, similarly to the method used in Deng et al. [9, 10] . For a gene g i that encodes protein in a complex, let
be the prior probability, where A is the number of disease genes for a specific disease in the complex, and B is the number of all disease genes in the complex. If a gene appears in multiple protein complexes, we use the maximum value as the prior probability for the gene. For those genes that do not belong to any protein complex, let
as the prior probability, where C is the number of all currently known disease genes for the specific disease, and D is the total number of genes in human genome.
Specifying an iteration loop
During the Gibbs sampling procedure, a "burn-in period" and a "lag period" often need to be specified. The "burn-in period" is the period that a Markov chain takes to become stabilized. Simulation results in this period are discarded to reduce the effect of initial prior probabilities. The "lag period" is the period that needs to reduce the dependence of the Markov process. The posterior probabilities in this period are estimated by averaging simulation results during individual lag steps. In paper [20] , we have shown that an additional "prediction period" is helpful to generate more stable and reliable predictions, which is the period used to generate final prediction by averaging all simulation results during this period. In this study, the "burn-in period" takes 100 steps, the "lag period" takes 90 steps and the "prediction period" takes 100 steps. Simulation results are averaged every 10 steps in the "lag period". There are 1100 steps in total for simulations.
Validation method and evaluation criteria
The leave-one-out cross validation paradigm is employed to evaluate the proposed method. For each known disease gene with at least one annotated interaction partner in a biological network, we assume it is an unknown gene and predict its posterior probability by the proposed method. The receiver operating characteristic (ROC) curve is employed as one of the evaluation criteria, which shows the relationship between the true positive rate (TPR) and the false positive rate (FPR) by varying the threshold for declaring positives. The area under the ROC curve (AUC) is also employed to show an overall performance of an algorithm. The negative control set consists of known disease genes that do not belong to the current disease class, and they are also validated by using the leave-one-out cross validation paradigm. The application of the AUC score as the evaluation criterion is due to the fact that it is widely accepted by most researchers.
We compare the proposed method with four existing algorithms: (i) the random walk with restart (RWR) algorithm proposed by Köhler et al. [46] ; (ii) the data integration rank (DIR) algorithm proposed by Chen et al. [7] ; (iii) the original MRF method proposed by Deng et al. [10] (denoted as MRF-Deng hereafter) and (iv) our previous improved MRF method for identifying human disease genes [20] (denoted as IMRF hereafter). The RWR algorithm [46] is a typical data integration method that uses a mixed network, where vertices and edges of several biological networks are simply merged together, while our proposed method integrates those networks separately. The comparison between those two algorithms can show which manner of multiple data integration is better. The DIR algorithm [7] has a very good performance in terms of multiple data integration. It also employs diffusion kernels to integrate different networks separately, which yields better performance than many other data integration methods [7] . The comparison with the other two existing MRF methods demonstrates how much improvement can be obtained from the proposed method as well.
Decision score and declaration of positives
Different disease classes consist of different numbers of known disease genes, and thus the prediction results may not be good if a global threshold is used for all classes. Although one can directly use the posterior probabilities obtained from the Gibbs sampling to select candidate disease genes, we suggest using a percentage as a decision score to generate the finial predictions. Let ( )
be the set of final posterior probabilities for a specific disease class. The decision score q i of vertex i is defined as
The greater the decision score is for a gene, the more likely it is to associate with specific disease. All the ROC curves and the AUC scores of the proposed method are calculated according to the decision score hereafter.
Results
Stability and reliability of the kernel-based MRF method
We first investigate the stability and reliability of the kernel-based MRF method, by comparing the Markov processes of the proposed method and the MRF-Deng method. Figure 1 illustrates the variation of posterior probabilities over iteration steps and the final posterior probability distribution for the above two methods.
Firstly, by comparing Figure 1A and C, we can clearly find that the kernel-based MRF method is more stable than the MRF-Deng method. The change of posterior probability of the front method converges quickly and stays at a stable state.
Here, the variation of posterior probabilities for two consecutive steps is calculated from
where p i (t ) is the posterior probability P(
Secondly, predictions of the kernel-based MRF method are more reasonable compared with the MRF-Deng method. The parameters of the MRF-Deng method are estimated from subnetworks of known vertices, which may only be feasible when the subnetwork is large enough for estimating parameters precisely. When the MRF-Deng method is employed directly to identify human disease genes, there are approximately 25.82% unknown genes that are predicted as disease genes with a probability large than 0.95. This is unreasonably high in practice, since it contains too many false positive predictions. Figure 1D shows the final posterior probability distribution of the MRF-Deng method as an example.
On the other hand, the kernel-based MRF method works very well. Taking the endocrine disease class for example, which is illustrated in Figure 1B , most genes are predicted with a probability small than 0.1. Only a few significant vertices are predicted with higher probabilities. Predictions of the kernel-based MRF method are more reliable than the MRF-Deng method. 
Comparisons between different kernels
To test the contribution of graph kernels in the kernel based MRF method, three types of kernels are employed in our experiments. Figure 2 illustrates the cross-validation results in terms of ROC curves and the AUC score by integrating only three PPI networks and all five biological networks, respectively. The LED kernel achieves the best performance (AUC=0.753) when three PPI networks are integrated, while the MED kernel works best (AUC=0.771) when all five PPI networks are integrated. The similar performance of those kernels also supports the stability of the kernel based MRF method.
Generally, there is no such a kernel that works better than all other kernels in any situation. The LED kernel works better than the MED kernel when three networks are integrated. However, the difference of between those two AUC scores is not large in this situation. Besides, the MED kernel works much better than the LED kernel when five networks are integrated. Hence, the MED kernel is always suggested to be used for multiple data integration if no particular information is obtained.
Comparisons with existing methods
The kernel-based MRF method is compared with the RWR algorithm, the DIR algorithm, the MRF-Deng algorithm and the IMRF method. Figure 3 illustrates ROC cross-validation results by integrating all five biological networks. It can be seen from the figure that the kernel based MRF method performs best compared with the other four existing algorithms. The kernel-based MRF method achieves the highest AUC score at 0.771 by using the MED kernel, followed by the IMRF method (AUC=0.743), the DIR algorithm (AUC=0.691) and the RWR algorithm (AUC=0.676). The MRF-Deng method achieves the AUC score only at 0.551.
Discussion
In this paper, we have presented an improved kernel based MRF method for identifying human disease genes by integrating five biological networks. The presented method is not only flexible in terms of integrating different types of biological data, but also reliable in terms of identifying human disease genes. Three kinds of graph kernels are employed to capture relationships of all vertices based on their global neighborhood characteristics. An improved Gibbs sampling procedure and a novel parameter estimation method are then developed for the presented MRF method. The use of different kernels brings great improvement for the previous MRF method. The proposed MED kernel works similar to the most commonly used LED kernel when three PPI networks are integrated, and it works best when five biological networks are integrated. Hence, the MED kernel is suggested to be used for the proposed algorithm when multiple data integration is involved to predict disease genes. Predictions by our presented method with integrating all five biological networks achieve the AUC score of 0.771 when the MED kernel is employed, which is very promising for identifying human disease genes.
